相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Combination testing of multidrug-resistant cystic fibrosis isolates of Pseudomonas aeruginosa: use of a new parameter, the susceptible breakpoint index
K. E. N. Milne et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2010)
Treatment of early Pseudomonas aeruginosa infection in patients with cystic fibrosis: the ELITE trial
Felix Ratjen et al.
THORAX (2010)
Early anti-pseudomonal acquisition in young patients with cystic fibrosis: Rationale and design of the EPIC clinical trial and observational study
Miriam M. Treggiari et al.
CONTEMPORARY CLINICAL TRIALS (2009)
Clinical impact of reducing routine susceptibility testing in chronic Pseudomonas aeruginosa infections in cystic fibrosis
Christine Etherington et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2008)
Breakpoints for predicting Pseudomonas aeruginosa susceptibility to inhaled tobramycin in cystic fibrosis patients:: Use of high-range etest strips
MI Morosini et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2005)
Combination antibiotic susceptibility testing to treat exacerbations of cystic fibrosis associated with multiresistant bacteria: a randomised, double-blind, controlled clinical trial
SD Aaron et al.
LANCET (2005)
Phenotypic variability of Pseudomonas aeruginosa in sputa from patients with acute infective exacerbation of cystic fibrosis and its impact on the validity of antimicrobial susceptibility testing
JE Foweraker et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2005)
PCR-Based assay for differentiation of Pseudomonas aeruginosa from other Pseudomonas species recovered from cystic fibrosis patients
T Spilker et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)